CTNT vs NBIX · rev $1.3M vs P/E 45, rev $1.77B
Cheetah Net Supply Chain Service Inc. Class A Common Stock (CTNT) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Cheetah Net Supply Chain Service Inc. Class A Common Stock (CTNT) is a integrated freight & logistics company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTNT revenue for 2025-12-31 was $1.3M. Net income was -$3.6M. Revenue was up 182.7% from 2024-12-31 to 2025-12-31. CTNT currently screens at market cap $4.9M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
CTNT currently screens at market cap $4.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the CTNT and NBIX stock pages for the full models.
Not investment advice.